120 related articles for article (PubMed ID: 11515819)
1. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.
Matsumoto M; Seya T; Kikkawa S; Tsuji S; Shida K; Nomura M; Kurita-Taniguchi M; Ohigashi H; Yokouchi H; Takami K; Hayashi A; Azuma I; Masaoka T; Kodama K; Toyoshima K; Higashiyama M
Int Immunopharmacol; 2001 Aug; 1(8):1559-69. PubMed ID: 11515819
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.
Begum NA; Ishii K; Kurita-Taniguchi M; Tanabe M; Kobayashi M; Moriwaki Y; Matsumoto M; Fukumori Y; Azuma I; Toyoshima K; Seya T
Infect Immun; 2004 Feb; 72(2):937-48. PubMed ID: 14742539
[TBL] [Abstract][Full Text] [Related]
4. Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton.
Seya T; Matsumoto M; Tsuji S; Begum NA; Nomura M; Azuma I; Hayashi A; Toyoshima K
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S13-21. PubMed ID: 11603865
[TBL] [Abstract][Full Text] [Related]
5. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract][Full Text] [Related]
6. Does the cell wall skeleton from Bacille Calmette-Guérin directly induce interferon-gamma, independent of interleukin-12?
Hayashi A; Noda A
Jpn J Clin Oncol; 1996 Jun; 26(3):124-7. PubMed ID: 8656550
[TBL] [Abstract][Full Text] [Related]
7. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
8. A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.
Kativhu CL; Libraty DH
PLoS One; 2016; 11(8):e0162148. PubMed ID: 27571272
[TBL] [Abstract][Full Text] [Related]
9. Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.
Kodama K; Higashiyama M; Takami K; Oda K; Okami J; Maeda J; Akazawa T; Matsumoto M; Seya T; Wada M; Toyoshima K
Surg Today; 2009; 39(3):194-200. PubMed ID: 19280277
[TBL] [Abstract][Full Text] [Related]
10. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
Tsuji S; Matsumoto M; Takeuchi O; Akira S; Azuma I; Hayashi A; Toyoshima K; Seya T
Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
[TBL] [Abstract][Full Text] [Related]
11. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
12. Development of immunoadjuvants for immunotherapy of cancer.
Azuma I; Seya T
Int Immunopharmacol; 2001 Jul; 1(7):1249-59. PubMed ID: 11460306
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene.
Fujii R; Iwahashi M; Kikkawa K; Inagaki T; Kohjimoto Y; Ojima T; Mori T; Kuramoto T; Nishizawa S; Azuma I; Yamaue H; Shinka T; Hara I
BJU Int; 2009 Dec; 104(11):1766-73. PubMed ID: 20063450
[TBL] [Abstract][Full Text] [Related]
14. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
Murata M
Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
[TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
Kato T; Bilim V; Yuuki K; Naito S; Yamanobe T; Nagaoka A; Yano I; Akaza H; Tomita Y
Anticancer Res; 2010 Oct; 30(10):4089-96. PubMed ID: 21036724
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.
Hayashi A; Nishida Y; Yoshii S; Kim SY; Uda H; Hamasaki T
Cancer Sci; 2009 Oct; 100(10):1991-5. PubMed ID: 19656158
[TBL] [Abstract][Full Text] [Related]
18. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy.
Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK
Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
20. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
